title: Increased red blood cell survival reduces the need of erythropoietin in hemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane.
authors.affiliation: Servizi di Nefrologia e Dialisi, Ospedale di Leno, BS, Italia.
authors.forename: M
authors.initials: M
authors.lastname: Usberti
authors.forename: G
authors.initials: G
authors.lastname: Bufano
authors.forename: G
authors.initials: G
authors.lastname: Lima
authors.forename: R M
authors.initials: RM
authors.lastname: Gazzotti
authors.forename: P
authors.initials: P
authors.lastname: Tira
authors.forename: G
authors.initials: G
authors.lastname: Gerardi
authors.forename: D
authors.initials: D
authors.lastname: Di Lorenzo
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000494:pharmacology*; D002482:Cellulose; D004905:Erythrocyte Aging; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005978:Glutathione / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D018384:Oxidative Stress; D006435:Renal Dialysis; D014810:Vitamin E / Q000097:blood / Q000494:pharmacology*
chemical_list: D000975:Antioxidants; D008567:Membranes, Artificial; D004921:Erythropoietin; D014810:Vitamin E; D002482:Cellulose; D005978:Glutathione